Board Of Directors

TrueVision's distinguished board of directors is comprised of both surgeons and business executives with extensive experience in medical digital imaging, surgical devices, and early stage technology ventures.

ARTHUR RICE III, BOARD MEMBER, CHAIRMAN: was one of the founders of, the most successful startup in the history of Santa Barbara. He served in many roles, but lastly as Director of Marketing before retiring to take an active role as an angel investor in early stage companies. Prior to, Mr. Rice held sales and marketing positions for several companies in the microwave communication and ultrasonic technology spaces. He currently serves as a director and/or advisor to many early to mid stage companies. Mr. Rice is an Electrical Engineering graduate of Rensselaer Polytechnic Institute.

BURTON TRIPATHI, PhD, CHIEF EXECUTIVE OFFICER, CHIEF TECHNOLOGY OFFICER, AND BOARD MEMBER: has over 15 years of experience developing and marketing innovative medical device technology. As senior manager for the Lap-Band® business at Allergan (previously Inamed), Dr. Tripathi managed an $8 million direct-to-consumer advertising campaign. Prior to that he was the product manager for robotic surgical systems at Computer Motion, Inc. (now Intuitive Surgical), where he determined market opportunities, established product pricing, delivered sales training presentations, created ROI models, and identified additional revenue potential for current products. Previously, Dr. Tripathi worked as a management consultant at McKinsey & Co. where he focused on high-tech, life sciences, and corporate finance work, including assignments with medical device, semiconductor, and pharmaceutical companies. Dr. Tripathi received his Ph.D. from the California Institute of Technology in Mechanical Engineering/Material Science and his B.S. in Mechanical Engineering from Cornell University.

FORREST FLEMING, BOARD MEMBER and CEO Emeritus: Mr. Fleming served as the CEO and Board Member for TrueVision from 2006 to 2018. He has a distinguished track record of creating successful start-up companies across a diverse industry portfolio, specializing in creating, funding, and executing business plans to optimally commercialize world-changing inventions. Prior to TrueVision, Mr. Fleming was CEO of ScentAir Technologies, a pioneer in creating scent-marketing solutions for retail environments and consumer brand promotions. He also has held senior sales and marketing positions for several successful early stage Companies including Parametric Technology (professional engineering software), Celera Genomics (drug discovery), and Cinesite, a division of Kodak (digital imaging services). He holds a B.S. degree in Industrial Technology from California Polytechnic University at San Luis Obispo, California.

FRED GLUCK, BOARD MEMBER: was with McKinsey and Co. from 1967 to 1995 and led the global Firm as its Managing Director from 1988 through 1994. Subsequent to his retirement, he joined the Bechtel Corporation and served as vice-chairman and Director. Mr. Gluck was with Bell Telephone Laboratories from 1957 to 1967 and was the program manager for the development of the Spartan anti-ICBM missile system. He has also served on the Boards of Amgen, the Hospital Corporation of America (HCA, lead director), the Cottage Health System and the New York Hospital (vice chairman). He holds a B.S.E.E from Manhattan College and an M.S.E.E from New York University.

SIMON RAAB, PhD, BOARD MEMBER: is the founder of Faro Technologies (FARO: NASDAQ) where he remains Chairman of the Board. He served as Chief Executive Officer of the Company from its inception in 1982 until January 2006. Mr Raab holds more than 80 US patents with associated foreign patents in fields of 3D coordinate measuring systems, biomaterials, and medical diagnostics. Mr. Raab holds a Ph.D. in Mechanical Engineering from McGill University, Montreal, Canada, a Masters of Engineering Physics from Cornell University and a Bachelor of Science in Physics with a minor in Biophysics from the University of Waterloo, Canada.

WILLIAM J LINK, PhD, BOARD MEMBER: is a leader in the healthcare industry. He is a Co -Founder and Managing Director of Versant Ventures, a leading venture capital firm focused in healthcare. At Versant, Bill has specialized in investing and building some of the most successful and innovative Medical Device Companies over the last 25 years. Prior to entering venture capital, Bill founded two companies which still today are leaders in the field of surgical ophthalmology. In 1987 Bill founded, and served as chairman and CEO of Chiron Vision, a subsidiary of Chiron Corporation specializing in ophthalmic surgical products. Chiron Vision was sold to Bausch and Lomb in 1997. Prior to Chiron Vision, Bill founded and served as President of American Medical Optics (AMO), a division of American Hospital Supply Corporation, which was sold to Allergan in 1986. Later Bill served on the Board of AMO’s successor company, Advanced Medical Optics (AMO) which was acquired by Abbott in 2009. Bill serves on the Board of several private companies and is on the Board of three public companies, Glaukos (GKOS), Second Sight (EYES) and Edwards Life Sciences (EW). Before entering the healthcare industry, Bill was an Assistant Professor in the Department of Surgery at the Indiana University School of Medicine. Bill received his BS, MS and PhD in Mechanical Engineering from Purdue University.

AIDAN FOLEY, BOARD MEMBER: has over 20 years of executive level management experience in the technology and entertainment industries. In technology, Mr. Foley has managed organizations, at executive levels, of software, hardware and services businesses on a global basis with a focus towards digital imaging. Prior to his current role as founder and CEO of AF Double Eagle, a corporate development and distribution company, Mr. Foley was the Chief Marketing Officer and President of the Enterprise Solutions Group of Ascent Media, an 800 million dollar global organization of Liberty Media. Prior to Ascent Media, Mr. Foley was the CEO of Kodak's Digital Entertainment Division. Mr. Foley is a member of the Society of Motion Picture and Television Engineers (SMPTE), the Academy of Television Arts and Sciences (ATAS) and the Producers Guild. His organizations have won awards for technical achievement including an Oscar and an Emmy.

DR. KEVIN FOLEY, BOARD MEMBER: is a Professor of Neurosurgery at the University of Tennessee, Memphis, and holds academic appointments at the University of Tennessee School of Biomedical Engineering and the Uniformed Services University for the Health Sciences in Bethesda, Maryland. He serves as Director of Complex Spine Surgery at Semmes-Murphey Clinic, Director of the Spine Fellowship Program for the University of Tennessee, Department of Neurosurgery, and Medical Director for both the Medical Education & Research Institute and the Image-Guided Surgery Research Center. Dr. Foley received his Doctor of Medicine degree from UCLA in 1979. During his training and throughout his career he has received numerous awards, including the Eben J. Carey Memorial Anatomy Award, the Merck Manual Award for Academic Achievement, the Letterman Army Medical Center’s Richard Mason Award for Outstanding Intern, the Army Commendation Medal, the Meritorious Service Medal with two Oak Leaf Clusters, the Order of Military Medical Merit, and the Surgeon General’s Physician Recognition Award.

FLAGG FLANAGAN, BOARD MEMBER: is a lead investor, CEO and Chairman of the Board for DiscGenics Inc, a step-ahead biotechnology company focused on spinal therapies for patients with chronic intervertebral disc diseases. In addition to serving on TrueVision's Board of Directors, Mr. Flanagan also serves on the Board of Directors at Image Stream Medical, Inc. Flanagan started his early career as the founder of Flanagan Instruments Inc., a regional surgical specialty distribution business focused on Zeiss surgical microscopes and other microsurgery and spinal products. Before being sold in 2005 to Japanese Itochu International, Flanagan Instruments grew from a small, two-state distribution business to a successful, eight-state $30 million business, becoming Zeiss' largest US distributor. Complementing his undergraduate college studies in Florida and North Carolina, Mr. Flanagan completed the prestigious Harvard Business School's Owner/President Management Program in 2001.